Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer’s and Parkinson’s diseases-Reference-Cited by-同舟云学术

Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer’s and Parkinson’s diseases

Published:2020-10-26 Issue:11 Volume:52 Page:1158-1168
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Corces M. Ryan^ORCID,Shcherbina Anna,Kundu Soumya,Gloudemans Michael J.^ORCID,Frésard Laure,Granja Jeffrey M.,Louie Bryan H.,Eulalio Tiffany^ORCID,Shams Shadi,Bagdatli S. Tansu,Mumbach Maxwell R.,Liu Boxiang^ORCID,Montine Kathleen S.,Greenleaf William J.^ORCID,Kundaje Anshul^ORCID,Montgomery Stephen B.^ORCID,Chang Howard Y.^ORCID,Montine Thomas J.^ORCID

Funder

U.S. Department of Health & Human Services | National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

https://www.nature.com/articles/s41588-020-00721-x.pdf

Reference90 articles.

1. Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat. Genet. 51, 414–430 (2019).

2. Jansen, I. E. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat. Genet. 51, 404–413 (2019).

3. Lambert, J.-C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat. Genet. 45, 1452–1458 (2013).